JY
BNTX icon

Jeff Yass’s BioNTech BNTX Stock Holding History

Jeff Yass’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Sell
156,300
-40,500
-21% -$3.81M ﹤0.01% 2848
2026
Q1 		$17.5M Sell
196,800
-187,700
-49% -$19.3M ﹤0.01% 2394
2025
Q4 		$36.6M Buy
384,500
+93,100
+32% +$9.38M ﹤0.01% 1628
2025
Q3 		$28.7M Sell
291,400
-39,300
-12% -$4.2M ﹤0.01% 1839
2025
Q2 		$35.2M Sell
330,700
-6,400
-2% -$646K ﹤0.01% 1450
2025
Q1 		$30.7M Sell
337,100
-114,100
-25% -$12.8M 0.01% 1366
2024
Q4 		$51.4M Sell
451,200
-3,000
-0.7% -$342K 0.01% 1098
2024
Q3 		$53.9M Buy
454,200
+225,900
+99% +$20.8M 0.01% 1031
2024
Q2 		$18.3M Sell
228,300
-47,000
-17% -$4.3M ﹤0.01% 1819
2024
Q1 		$25.4M Sell
275,300
-73,300
-21% -$7.03M ﹤0.01% 1546
2023
Q4 		$36.8M Sell
348,600
-74,400
-18% -$7.5M 0.01% 1259
2023
Q3 		$46M Buy
423,000
+207,800
+97% +$23M 0.01% 1061
2023
Q2 		$23.2M Buy
215,200
+5,200
+2% +$585K ﹤0.01% 1584
2023
Q1 		$26.2M Sell
210,000
-291,000
-58% -$40M 0.01% 1444
2022
Q4 		$75.3M Sell
501,000
-21,500
-4% -$3.31M 0.02% 679
2022
Q3 		$70.5M Sell
522,500
-95,800
-15% -$14.6M 0.02% 648
2022
Q2 		$92.2M Sell
618,300
-85,100
-12% -$13M 0.02% 555
2022
Q1 		$120M Sell
703,400
-765,400
-52% -$129M 0.02% 578
2021
Q4 		$379M Sell
1,468,800
-199,900
-12% -$54.7M 0.06% 279
2021
Q3 		$456M Buy
1,668,700
+688,300
+70% +$219M 0.06% 261
2021
Q2 		$219M Buy
980,400
+109,400
+13% +$20.6M 0.03% 467
2021
Q1 		$95.1M Buy
871,000
+510,200
+141% +$54.2M 0.02% 755
2020
Q4 		$29.4M Sell
360,800
-17,900
-5% -$1.76M ﹤0.01% 1390
2020
Q3 		$26.2M Buy
378,700
+296,800
+362% +$21.3M 0.01% 1262
2020
Q2 		$5.47M Buy
+81,900
New +$4.09M ﹤0.01% 2885

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Jeff Yass's BNTX Position: Q2 2026 in Review

Jeff Yass reduced its BioNTech (BNTX) stake by 35% in Q2 2026, selling an estimated $6.29M and leaving 126,616 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3128.

Jeff Yass first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $253M in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Jeff Yass held 126,616 shares of BioNTech worth $11.8M as of Q2 2026.
  • Jeff Yass sold 66,845 BioNTech shares in Q2 2026, an estimated $6.29M.
  • BioNTech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #3128 holding.
  • Jeff Yass first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Jeff Yass's BioNTech position peaked at $253M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.